Sana Biotechnology (SANA) Profit After Tax (2020 - 2026)

Sana Biotechnology's Profit After Tax history runs 7 years deep, the most recent figure standing at -$47.2 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 4.41% year-over-year to -$47.2 million; the TTM figure through Mar 2026 stood at -$242.0 million (down 15.96% YoY), while the FY2025 annual figure was -$244.2 million, up 8.47% from the prior year.
• Profit After Tax came in at -$47.2 million for Q1 2026 at Sana Biotechnology, up from -$58.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $984000.0 in Q3 2023 to a low of -$114.0 million in Q2 2023.
• A 5-year average of -$65.3 million and a median of -$59.9 million in 2024 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax soared 101.16% in 2023 and slumped 6189.84% in 2024, its largest moves.
• Sana Biotechnology's Profit After Tax stood at -$80.4 million in 2022, then slipped by 9.54% to -$88.1 million in 2023, then jumped by 44.31% to -$49.1 million in 2024, then fell by 19.88% to -$58.8 million in 2025, then increased by 19.75% to -$47.2 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$47.2 million, -$58.8 million, and -$42.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison